Immune-Related Adverse Events: Pneumonitis

被引:19
|
作者
Jain, Akash [1 ]
Shannon, Vickie R. [1 ]
Sheshadri, Ajay [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA
来源
IMMUNOTHERAPY, 2ND EDITION | 2018年 / 995卷
关键词
Checkpoint inhibitors; Immune-related adverse event; Pneumonitis; Thoracic imaging; Organizing pneumonia; Nonspecific interstitial pneumonia; Hypersensitivity pneumonitis; Diffuse alveolar damage; NONSPECIFIC INTERSTITIAL PNEUMONIA; RESPIRATORY-DISTRESS-SYNDROME; OBLITERANS ORGANIZING PNEUMONIA; IDIOPATHIC PULMONARY-FIBROSIS; INHIBITOR-RELATED PNEUMONITIS; BRONCHIOLITIS OBLITERANS; COMPUTED-TOMOGRAPHY; METASTATIC MELANOMA; T-CELLS; HYPERSENSITIVITY PNEUMONITIS;
D O I
10.1007/978-3-030-02505-2_6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Checkpoint inhibitors are part of the family of immunotherapies and are increasingly being used in a wide variety of cancers. Immune-related adverse events pose a major challenge in the treatment of cancer patients. Pneumonitis is a rare immune-related adverse event that presents in distinct patterns. The goal of this chapter is to instruct readers on the incidence and clinical manifestations of pneumonitis and to offer guidance in the evaluation and treatment of patients with pneumonitis.
引用
收藏
页码:131 / 149
页数:19
相关论文
共 50 条
  • [31] Immune-related adverse events and the balancing act of immunotherapy
    Michael Conroy
    Jarushka Naidoo
    [J]. Nature Communications, 13
  • [32] Hypersensitivity and Immune-related Adverse Events in Biologic Therapy
    Waldron, Jamie L.
    Schworer, Stephen A.
    Kwan, Mildred
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 62 (03) : 413 - 431
  • [33] Histologic Patterns of Immune-Related Adverse Events in the Colon
    Zhang, Mingjuan
    Neyaz, Azfar
    Shih, Angela
    Patil, Deepa
    Deshpande, Vikram
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 813 - 813
  • [34] Clinical and translational attributes of immune-related adverse events
    Suijkerbuijk, Karijn P. M.
    van Eijs, Mick J. M.
    van Wijk, Femke
    Eggermont, Alexander M. M.
    [J]. NATURE CANCER, 2024, 5 (4) : 557 - 571
  • [35] Clinical and biological correlates of immune-related adverse events
    von Itzstein, Mitchell S.
    Sheffield, Thomas
    Burke, Michael C.
    Hsiehchen, David
    Fattah, Farjana
    Mu-Mosley, Hong
    Park, Jason Y.
    Khan, Shaheen
    Ostmeyer, Jared
    Dowell, Jonathan E.
    Homsi, Jade
    Saltarski, Jessica M.
    Gloria-McCutchen, Yvonne
    Xie, Yang
    Li, Quan-Zhen
    Wakeland, Edward K.
    Gerber, David E.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 90 - 90
  • [36] Immune-Related Adverse Events in Patients with Lung Cancer
    Guilherme Sacchi de Camargo Correia
    Tanmayi Pai
    Shenduo Li
    Dana Connor
    Yujie Zhao
    Yanyan Lou
    Rami Manochakian
    [J]. Current Oncology Reports, 2023, 25 : 1259 - 1275
  • [37] Strategies for improving the management of immune-related adverse events
    Naing, Aung
    Hajjar, Joud
    Gulley, James L.
    Atkins, Michael B.
    Ciliberto, Gennaro
    Meric-Bernstam, Funda
    Hwu, Patrick
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [38] ANALYSIS OF IMMUNE-RELATED ADVERSE EVENTS WITH CONSULTATION TO GASTROENTEROLOGISTS
    Sakamaki, Akira
    Kamimura, Kenya
    Arao, Yoshihisa
    Setsu, Toru
    Yokoo, Takeshi
    Kamimura, Hiroteru
    Tsuchiya, Atsunori
    Takamura, Masaaki
    Terai, Shuji
    [J]. HEPATOLOGY, 2019, 70 : 1228A - 1228A
  • [39] Predictors of immunotherapy induced immune-related adverse events
    Barata, Margarida
    Santos, Gabriela
    Grumete, Helena
    Lopes, Miguel
    Canario, Dolores
    Duarte, Jose
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [40] Cutaneous immune-related adverse events to checkpoint inhibitors
    Malviya, Neeta
    Tattersall, Ian W.
    Leventhal, Jonathan
    Allon, Allireza
    [J]. CLINICS IN DERMATOLOGY, 2020, 38 (06) : 660 - 678